Chile vs Slovenia: Cause of death, by non-communicable diseases, ages 5-14, male
Chile
56.1%
in 2021
Slovenia
57.7%
in 2021
Chile rank
36th
Slovenia rank
33rd
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Chile
- Slovenia
How they compare
Slovenia currently reports 57.7% against 56.1% in Chile, a difference of 1.6%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Chile ahead.
Chile ranks 36th and Slovenia ranks 33rd of 185 countries.
Across the 3 decades both report, Chile averaged higher in 2 and Slovenia in 1.
Head to head by decade
| Decade | Chile | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 48.5% | 46.8% | 1.7% | Chile |
| 2010s | 55.1% | 60.0% | 4.8% | Slovenia |
| 2020s | 58.8% | 49.1% | 9.8% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Chile or Slovenia?
- Slovenia, at 57.7% against 56.1% in Chile as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Chile and Slovenia?
- 1.6%, with Slovenia ahead.
- How many years of comparable data are there for Chile and Slovenia?
- 6 years are reported by both, from 2000 to 2021.
- How do Chile and Slovenia rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Chile ranks 36th and Slovenia ranks 33rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.